celastrol has been researched along with selenium in 2 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (selenium) | Trials (selenium) | Recent Studies (post-2010) (selenium) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 23,829 | 969 | 8,890 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Li, Y; Luo, C; Sun, S; Zhang, X; Zhu, M; Zhu, S | 1 |
| Chen, Q; Fan, J; Liu, S; Ren, Y; Yan, L; Zhang, X; Zhu, S | 1 |
2 other study(ies) available for celastrol and selenium
| Article | Year |
|---|---|
Selenium-deposited tripterine phytosomes ameliorate the antiarthritic efficacy of the phytomedicine via a synergistic sensitization.
Topics: Animals; Antirheumatic Agents; Caco-2 Cells; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Synergism; Humans; Inflammation; Liposomes; Male; Nanoparticles; Particle Size; Pentacyclic Triterpenes; Phytotherapy; Rats; Rats, Sprague-Dawley; Selenium; Triterpenes | 2020 |
Phytosomal tripterine with selenium modification attenuates the cytotoxicity and restrains the inflammatory evolution via inhibiting NLRP3 inflammasome activation and pyroptosis.
Topics: Animals; Caspases; Inflammasomes; Inflammation; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Pyroptosis; Selenium | 2022 |